Hepatitis C Virus Testing Among Perinatally Exposed Children: 2018 to 2020

To assess the frequency of hepatitis C virus (HCV) testing among a population-based cohort of perinatally exposed children and identify factors associated with testing. Using a population-based surveillance cohort of perinatally exposed children born from 2018 to 2020 from 4 US jurisdictions (Georgi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatrics (Evanston) 2024-12, Vol.154 (6)
Hauptverfasser: Woodworth, Kate R, Distler, Samantha, Chang, Daniel J, Luong, Jackie, Newton, Suzanne, Akosa, Amanda, Orkis, Lauren, Reynolds, Bethany, Carpentieri, Cynthia, Willabus, Teri, Osinski, Anthony, Shephard, Hanna, Halai, Umme-Aiman, Lyu, Caleb, Sizemore, Lindsey, Sandul, Amy, Tong, Van T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To assess the frequency of hepatitis C virus (HCV) testing among a population-based cohort of perinatally exposed children and identify factors associated with testing. Using a population-based surveillance cohort of perinatally exposed children born from 2018 to 2020 from 4 US jurisdictions (Georgia; Massachusetts; Allegheny County, Pennsylvania; and Los Angeles County, California), we describe the frequency, timing, and type of HCV testing among children and identify characteristics associated with having an HCV test result by the age of 2 to 3 years. Data were obtained from electronic laboratory reporting, vital records, and medical records. Of 803 perinatally exposed children, 7 (1%) died before the age of 24 months. Of 796 children, health departments were unable to find medical records or laboratory reports for 181 (23%). Among those with medical record abstraction at 24 months or testing reported before the age of 3 years (n = 615), 50% had an HCV test. The majority (70% of those tested) were tested for HCV antibodies at the age of 18 months or later, although 9% had an HCV nucleic acid test at ages 2 to
ISSN:0031-4005
1098-4275
1098-4275
DOI:10.1542/peds.2024-067261